Search

everythinglearnresearchcommunity

for

Search:↓

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The compound 4c effectively inhibits the enzyme linked to hair loss.

D'orenone stops root hair growth by disrupting auxin transport, but adding auxin can reverse this.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

TAK-279 effectively reduces psoriasis symptoms and is safe.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Finasteride boosts morphine's pain relief and prevents tolerance and withdrawal in rats.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Gene variation affects prostate issues and hair loss.

Carvacrol activates the TRPV3 channel, which may help design new skin treatments.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

SARMs work differently in tissues due to unique interactions and structures.

A(1-7) treatment reduces symptoms of lupus in mice.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.